Hepatocyte nuclear factor 1 alpha is a factor responsible for the interindividual variation of OATP1B1 mRNA levels in adult Japanese livers

Pharmaceutical Research

Volumn 24, Issue 12, 2007, Pages 2327-2332

  Furihata, Tomomi ^a   Satoh, Tomomi ^a   Yamamoto, Naoko ^a   Kobayashi, Kaoru ^a   Chiba, Kan ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Hepatocyte nuclear factor 1 ; Interindividual variability; Liver; Organic anion transporting polypeptide 1B1; Transcriptional regulation

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1ALPHA; LUCIFERASE; MESSENGER RNA; ORGANIC ANION TRANSPORTER 1;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; LIVER EXAMINATION; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENES, REPORTER; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; JAPAN; LIVER; LUCIFERASES; MALE; MIDDLE AGED; ORGANIC ANION TRANSPORTERS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 35848929707     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9458-2     Document Type: Article

References (26)

1. B. Hagenbuch, and P. J. Meier. The superfamily of organic anion transporting polypeptides. Biochim. Biophys. Acta 1609:1-18 (2003).
2. G. A. Kullak-Ublick, B. Stieger, and P. J. Meier. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126:322-342 (2004).
3. Y. Kameyama, K. Yamashita, K. Kobayashi, M. Hosokawa, and K. Chiba. Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells. Pharmacogenet. Genomics 15:513-522 (2005).
4. M. Niemi, E. Schaeffeler, T. Lang, M. F. Fromm, M. Neuvonen, C. Kyrklund, J. T. Backman, R. Kerb, M. Schwab, P. J. Neuvonen, M. Eichelbaum, and K. T. Kivisto. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1). Pharmacogenetics 14:429-440 (2004).
5. Y. Nishizato, I. Ieiri, H. Suzuki, M. Kimura, K. Kawabata, T. Hirota, H. Takane, S. Irie, H. Kusuhara, Y. Urasaki, A. Urae, S. Higuchi, K. Otsubo, and Y. Sugiyama. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin. Pharmacol. Ther. 73:554-565 (2003).
6. C. S. Huang, M. J. Huang, M. S. Lin, S. S. Yang, H. C. Teng, and K. S. Tang. Genetic factors related to unconjugated hyperbilirubinemia amongst adults. Pharmacogenet. Genomics 15:43-50 (2005).
7. Y. Cui, J. Konig, A. T. Nies, M. Pfannschmidt, M. Hergt, W. W. Franke, W. Alt, R. Moll, and D. Keppler. Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma. Lab. Invest. 83:527-538 (2003).
8. M. Oswald, G. A. Kullak-Ublick, G. Paumgartner, and U. Beuers. Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis. Liver. 21:247-253 (2001).
9. M. Kinoshita, and M. Miyata. Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci. Hepatology 36:433-438 (2002).
10. G. Zollner, M. Wagner, P. Fickert, D. Silbert, A. Fuchsbichler, K. Zatloukal, H. Denk, and M. Trauner. Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int. 25:367-379 (2005).
11. R. H. Ho, R. G. Tirona, B. F. Leake, H. Glaeser, W. Lee, C. J. Lemke, Y. Wang, and R. B. Kim. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology 130:1793-1806 (2006).
12. D. Jung, B. Hagenbuch, L. Gresh, M. Pontoglio, P. J. Meier, and G. A. Kullak-Ublick. Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1 alpha. J. Biol. Chem. 276:37206-37214 (2001).
13. M. Niemi, J. T. Backman, L. I. Kajosaari, J. B. Leathart, M. Neuvonen, A. K. Daly, M. Eichelbaum, K. T. Kivisto, and P. J. Neuvonen. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics. Clin. Pharmacol. Ther. 77:468-478 (2005).
14. T. Furihata, M. Hosokawa, M. Masuda, T. Satoh, and K. Chiba. Hepatocyte nuclear factor-4alpha plays pivotal roles in the regulation of mouse carboxylesterase 2 gene transcription in mouse liver. Arch. Biochem. Biophys. 447:107-117 (2006).
15. J. B. de Kok, R. W. Roelofs, B. A. Giesendorf, J. L. Pennings, E. T. Waas, T. Feuth, D. W. Swinkels, and P. N. Span. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab. Invest. 85:154-159 (2005).
16. J. Antonov, D. R. Goldstein, A. Oberli, A. Baltzer, M. Pirotta, A. Fleischmann, H. J. Altermatt, and R. Jaggi. Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab. Invest. 85:1040-1050 (2005).
17. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and F. Speleman. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:RESEARCH0034 (2002).
18. T. Furihata, M. Hosokawa, F. Nakata, T. Satoh, and K. Chiba. Purification, molecular cloning, and functional expression of inducible liver acylcarnitine hydrolase in C57BL/6 mouse, belonging to the carboxylesterase multigene family. Arch. Biochem. Biophys. 416:101-109 (2003).
19. T. Furihata, M. Hosokawa, T. Satoh, and K. Chiba. Synergistic role of specificity proteins and upstream stimulatory factor 1 in transactivation of the mouse carboxylesterase 2/microsomal acylcarnitine hydrolase gene promoter. Biochem. J. 384:101-110 (2004).
20. K. Kobayashi, S. Yamagami, T. Higuchi, M. Hosokawa, and K. Chiba. Key structural features of ligands for activation of human pregnane X receptor. Drug. Metab. Dispos. 32:468-472 (2004).
21. A. del Castillo-Olivares, J. A. Campos, W. M. Pandak, and G. Gil. The role of alpha1-fetoprotein transcription factor/LRH-1 in bile acid biosynthesis: a known nuclear receptor activator that can act as a suppressor of bile acid biosynthesis. J. Biol. Chem. 279:16813-16821 (2004).
22. F. M. Giuffrida, and A. F. Reis. Genetic and clinical characteristics of maturity-onset diabetes of the young. Diabetes Obes. Metab. 7:318-326 (2005).
23. S. Ellard. Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. Hum. Mutat. 16:377-385 (2000).
24. P. Boileau, C. Wolfrum, D. Q. Shih, T. A. Yang, A. W. Wolkoff, and M. Stoffel. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3). Diabetes 51:S343-S348 (2002).
25. J. M. Maher, A. L. Slitt, T. N. Callaghan, X. Cheng, C. Cheung, F. J. Gonzalez, and C. D. Klaassen. Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. Biochem. Pharmacol. 72:512-522 (2006).
26. D. Q. Shih, M. Bussen, E. Sehayek, M. Ananthanarayanan, B. L. Shneider, F. J. Suchy, S. Shefer, J. S. Bollileni, F. J. Gonzalez, J. L. Breslow, and M. Stoffel. Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat. Genet. 27:375-382 (2001).